| Source: | Streptomyces argillaceus |
| Synonyms |
Name of Substance
Systematic Name
- D-threo-2-Pentulose,
5-deoxy-1-C-((2S,3S)-7-((2,6-dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-3-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-beta-D-lyxo-hexopyranosyl-
Synonyms
- A-2371
- Antibiotic LA 7017
- Aurelic acid
- Aureolic acid
- Aurlelic acid
- HSDB 3238
- Mithracin
- Mithramycin A
- NSC 24559
- PA 144
|
| Description: | Mithramycin A:
Oligosaccharide antibiotic, a RNA synthesis inhibitor |
| CAS number: | 18378-89-7 |
| Merck index: | 13,7619 |
| Molecular weight: | 1085 |
| Structure: | 
 |
| Molecular Formula: | C52H76O24 |
| Canonical SMILES: |
|
Solubility
information: | DMSO, Methanol, Ethanol |
| Specifications | |
| Appearance: | Yellow powder |
| Purity: | At least 95% by TLC, HPLC |
| λmax: | 280 |
| Melting point | 175°C-180°C |
| Solubility | |
| Storage | -20°C |
| Applications | DNA binding fluorescent dye.
Until 2000 it was used to reduce high levels of plasma calcium
Used as an antineoplastic agent |
| Warnings | HARMFUL |
| Classification | Anthracycline
Pentaglycosidic antibiotic
RNA synthesis inhibitor |
| Related products | Actinomycin D |
| | For Research use only. Not for Human or Drug use
GMP/API grade available on request
No genetically modified organisms are used. |
| Publications | |
| | |
| | |
|
Mithramycin on Wikipedia
|
Attention:
Also registered under CAS number 97666-60-9 |
| |
| Clinical perspectives
Mithramycin may be used against Huntington's disease (HD)
neurodegeneration |  |
|
